Skinvisible (SKVI) Stock Analysis & Winston Score

Skinvisible, Inc. is a small pharmaceutical and drug delivery company based in Nevada. It develops patented polymer-based technologies that help other companies deliver drugs or active ingredients through the skin more effectively. Its main customers are pharmaceutical and consumer health companies that license its technology to use in their own products. The company makes money primarily through licensing fees and royalties, meaning it earns a cut when partners use its delivery technology in their products rather than selling finished goods directly to consumers. It operates mainly in North America and is a very small company with a market cap near zero. Its core moat is its patented Invisicare polymer platform, which creates a barrier that holds active ingredients on the skin longer than standard formulas. The biggest risk the company faces is its heavy reliance on a small number of licensing partners, and its deeply negative operating margins show it currently spends far more than it earns.